Evidence map›Paper›PMID 25587897›Full record

ArticlePloS one2015

Detailed phenotypic and molecular analyses of genetically modified mice generated by CRISPR-Cas9-mediated editing.

Bijal A Parikh, Diana L Beckman, Swapneel J Patel, J Michael White, Wayne M Yokoyama

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. From amputations to antibiotics: A future beyond "hacksaw" gene editing.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. The technical risks of human gene editing.Human reproduction (Oxford, England) · 2019
    Article
  15. Article
  16. Off- and on-target effects of genome editing in mouse embryos.The Journal of reproduction and development · 2019
    Article
  17. Gene-edited CRISPy Critters for alcohol research.Alcohol (Fayetteville, N.Y.) · 2019
    Review
  18. Genome Editing in Mice Using CRISPR/Cas9 Technology.Current protocols in cell biology · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Bijal A ParikhDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, United States of America.
Diana L BeckmanDivision of Rheumatology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, United States of America.
Swapneel J PatelDivision of Rheumatology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, United States of America.
J Michael WhiteDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, United States of America.
Wayne M YokoyamaDivision of Rheumatology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, United States of America; Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO, 63110, United States of America.
Washington University in St. Louis · US

Funding

Viral Discovery in Rheumatoid ArthritisP30AR048335 · NIAMS · WASHINGTON UNIVERSITY · PI BYUN, MINJI · 2001 to 2015
$8.9M
MECHANISMS OF THE NATURAL KILLER CELL ANTIVIRAL EFFECTOR RESPONSEK08AI104991 · NIAID · WASHINGTON UNIVERSITY · PI PARIKH, BIJAL A. · 2013 to 2017
$844k
Howard Hughes Medical InstituteNIAID NIH HHS K08 AI104991NIAID NIH HHS K08-AI104991NIAMS NIH HHS P30 AR048335NIAMS NIH HHS P30-AR048335
6 · The paper itself

Abstract

The bacterial CRISPR-Cas9 system has been adapted for use as a genome editing tool. While several recent reports have indicated that successful genome editing of mice can be achieved, detailed phenotypic and molecular analyses of the mutant animals are limited. Following pronuclear micro-injection of fertilized eggs with either wild-type Cas9 or the nickase mutant (D10A) and single or paired guide RNA (sgRNA) for targeting of the tyrosinase (Tyr) gene, we assessed genome editing in mice using rapid phenotypic readouts (eye and coat color). Mutant mice with insertions or deletions (indels) in Tyr were efficiently generated without detectable off-target cleavage events. Gene correction of a single nucleotide by homologous recombination (HR) could only occur when the sgRNA recognition sites in the donor DNA were modified. Gene repair did not occur if the donor DNA was not modified because Cas9 catalytic activity was completely inhibited. Our results indicate that allelic mosaicism can occur following -Cas9-mediated editing in mice and appears to correlate with sgRNA cleavage efficiency at the single-cell stage. We also show that larger than expected deletions may be overlooked based on the screening strategy employed. An unbiased analysis of all the deleted nucleotides in our experiments revealed that the highest frequencies of nucleotide deletions were clustered around the predicted Cas9 cleavage sites, with slightly broader distributions than expected. Finally, additional analysis of founder mice and their offspring indicate that their general health, fertility, and the transmission of genetic changes were not compromised. These results provide the foundation to interpret and predict the diverse outcomes following CRISPR-Cas9-mediated genome editing experiments in mice.

Indexed as

CRISPR-Cas SystemsPhenotypeAllelesAnimalsClustered Regularly Interspaced Short Palindromic RepeatsGenomeMiceMice, TransgenicMonophenol MonooxygenaseRNA, Guide, CRISPR-Cas SystemsMonophenol MonooxygenaseRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID25587897
PMCPMC4294663
OpenAlexW2101123699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.